Abametapir

185 interactions 129 explained in plain English 2 cited references
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Major

Abametapir Lemborexant Dayvigo Explained Increased exposure of CYP3A4 substrate Details Abametapir Lercanidipine Explained Increased exposure of CYP3A4 substrate Details Abametapir Levamlodipine Conjupri Explained Increased exposure of CYP3A4 substrate Details Abametapir Lopinavir Explained Increased exposure of CYP3A4 substrate Details Abametapir Lorlatinib Lorbrena Explained Increased exposure of CYP3A4 substrate Details Abametapir Lumateperone Caplyta Increased exposure of CYP3A4 substrate Details Abametapir Lurbinectedin Zepzelca Explained Increased exposure of CYP3A4 substrate Details Abametapir Macimorelin Explained Increased exposure of CYP3A4 substrate Details Abametapir Maraviroc Selzentry Increased exposure of CYP3A4 substrate Details Abametapir Melatonin Explained Increased exposure of CYP1A2 substrates Details Abametapir Methadone Diskets Explained Increased exposure of CYP3A4 substrate Details Abametapir Mexiletine Mexitil® Increased exposure of CYP1A2 substrates Details Abametapir Naldemedine Symproic Increased exposure of CYP3A4 substrate Details Abametapir Naloxegol Movantik Increased exposure of CYP3A4 substrate Details Abametapir Nateglinide Starlix® Increased exposure of CYP3A4 substrate Details Abametapir Nelfinavir Viracept Explained Increased exposure of CYP3A4 substrate Details Abametapir Neratinib Nerlynx Increased exposure of CYP3A4 substrate Details Abametapir Netupitant Explained Increased exposure of CYP3A4 substrate Details Abametapir Nifedipine Adalat® Increased exposure of CYP3A4 substrate Details Abametapir Nilotinib Explained Increased exposure of CYP3A4 substrate Details Abametapir Nintedanib Ofev Increased exposure of CYP3A4 substrate Details Abametapir Nisoldipine Sular Increased exposure of CYP3A4 substrate Details Abametapir Olanzapine Explained Increased exposure of CYP1A2 substrates Details Abametapir Omeprazole Gastrobim Explained Increased exposure of CYP3A4 substrate Details Abametapir Ondansetron Explained Increased exposure of CYP3A4 substrate Details Abametapir Osilodrostat Isturisa Explained Increased exposure of CYP3A4 substrate Details Abametapir Paclitaxel Abraxane Explained Increased exposure of CYP3A4 substrate Details Abametapir Palbociclib Ibrance Explained Increased exposure of CYP3A4 substrate Details Abametapir Paritaprevir Explained Increased exposure of CYP3A4 substrate Details Abametapir Pemigatinib Pemazyre Explained Increased exposure of CYP3A4 substrate Details Abametapir Perampanel FYCOMPA Explained Increased exposure of CYP3A4 substrate Details Abametapir Pimozide Explained Increased exposure of CYP3A4 substrate Details Abametapir Pirfenidone Esbriet Explained Increased exposure of CYP1A2 substrates Details Abametapir Pitolisant Wakix Explained Increased exposure of CYP3A4 substrate Details Abametapir Pomalidomide Pomalyst Explained Increased exposure of CYP1A2 substrates Details Abametapir Progesterone Crinone Explained Increased exposure of CYP3A4 substrate Details Abametapir Propranolol Hemangeol Explained Increased exposure of CYP1A2 substrates Details Abametapir Quinidine Cardioquin® Explained Increased exposure of CYP3A4 substrate Details Abametapir Ranolazine Aspruzyo Explained Increased exposure of CYP3A4 substrate Details Abametapir Reboxetine Explained Increased exposure of CYP3A4 substrate Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.